Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hypertension
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Hypertension
    ONTARGET Substudy Shows No Benefits for Combination Therapy for Prevention of Vascular Events in High-Risk Patients: Presented at ASH(HYP) - (DGDispatch)
    Amlodipine Plus Valsartan Reduces Blood Pressure Reductions Better Than Monotherapy in Black Patients With Severe Hypertension: Presented at ASH(HYP) - (DGDispatch)
    TopAbstracts in Hypertension 05/14/2008 - (DGNews)
    TopAbstracts in Hypertension 05/07/2008 - (DGNews)
    Kidney Disease Substantially Worsens in One-Fourth of African Americans Despite Hypertension Treatment - (DGNews)

    News archive

     Recent webcasts/CME - Hypertension
    • Improving Outcomes in Hypertension and Congestive Heart Failure: Focus on New Generation ß-Blockers
    • Tackling a Silent Threat: Implications and Management of Peripheral Artery Disease
    • Peripheral Artery Disease: A Highly Prevalent Disease Remains Underdiagnosed and Undertreated
    • Pharmacotherapeutic Treatments for Hypertension Complicated with Proteinuria
      Hypertension in the Elderly

      Webcasts/CME archive

       Recent cases - Hypertension
        Dilation of Renal Artery Stenosis after Administration of Losartan
        Angioedema of the Tongue
        Primary Aldosteronism Caused by a Unilateral Adrenal Adenoma Accompanied by Autonomous Cortisol Secretion
        A Case of Hyperreninemic Hypertension with Bilateral Positive Captopril Renography but without Renovascular Stenosis
        Unusual Sequel of Successful Laparoscopic Unilateral Adrenalectomy in a Hypertensive Adolescent

        Cases archive
          




        my personal edition > hypertension > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Basal Nitric Oxide Production, Release Improved By AT(1) Receptor Blockade With Valsartan

        A DGReview of :"Effect of AT(1) receptor blockade on endothelial function in essential hypertension."
        American Journal of Hypertension

        02/19/2003
        Veronica Rose


        Basal nitric oxide production and release in hypertensive patients is improved with the AT(1) receptor blocker, valsartan, indicates recent research.

        Endothelial function and nitric oxide availability are adversely affected by angiotensin II, say researchers at the University of Erlangen- Nurnberg, Germany. Consequently, they undertook an analysis of the AT(1) receptor blockade effect on endothelium -dependent vasodilation and basal nitric oxide (NO) production, and release in 60 patients with essential hypertension.

        The patients, aged 53 ± 10 years, were randomised to six weeks of double-blind therapy with either valsartan (80mg), hydrochlorothiazide (25 mg) or a placebo, once daily.

        Basal nitric oxide production and release was assessed using a forearm blood flow measurement response to intra-arterial infusion of N(G)-monomethyl-L-arginine (L-NMMA). In addition, endothelium-dependent vasodilation was assessed by measuring the forearm blood flow (FBF) response to intra-arterial administration of acetylcholine. Endothelium-independent changes in FBF were assessed with intra-arterial infusion of noradrenaline and sodium nitroprusside.

        Following treatment with valsartan, the decreased forearm blood pressure responding to L-NMMA was augmented. However, no improvement was seen in patients who received either placebo or hydrochlorothiazide therapy.

        Decreased forearm blood flow, which was induced by changes in L-NMMA following valsartan therapy. proved to be unrelated to changes in blood pressure. The researchers also noted that there was no substantial modification of the FBF response induced by intra-arterial infusion of acetylcholine, noradrenaline and sodium nitroprusside.

        They concluded that since the blood pressure reduction with hydrochlorothiazide did not increase the availability of nitric oxide, the effect of AT1 receptor blockers were independent of the BP.
        American Journal of Hypertension 2003;16:2:123-128. "Effect of AT(1) receptor blockade on endothelial function in essential hypertension."

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send